Delivery Order SPE2DB20D2104-SPE2DB25FMURU

Award Date 7/3/25
Potential Completion Date 7/7/25
Potential Value $3.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,378.21 firm fixed-price contract is for the delivery of epinephrine 0.3 mg auto-injectors, with a completion date of January 10, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This is a delivery order contract awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $3,608.52 firm fixed price contract is for the supply of 4,564,491,963 units of Epinephrine 0.3 mg auto-injectors, with a completion date of May 6, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Epinephrine 0.3 mg auto-injector devices. The $1,683.55 firm-fixed-price contract has an ultimate completion date of July 3, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle for...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $1,596.24 firm fixed-price contract is for the supply of 4,567,997,553 units of epinephrine 0.3 mg auto-injectors. The award has an ultimate completion date of April 23, 2025 and is not designated as a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Epinephrine 0.3 mg auto-injectors. The firm-fixed-price contract, valued at $1,794.36, has an ultimate completion date of April 5, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as the primary vehicle for...
This is a delivery order awarded to Amerisourcebergen Drug Corp's Corporate Office division by the Defense Logistics Agency (DLA) for the provision of 4,564,702,555 epinephrine 0.3 mg auto-injectors. The $2,607.12 firm fixed-price contract has a completion date of May 24, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to supply a comprehensive range of pharmaceutical products and medical...
This is a delivery order awarded to Amerisourcebergen Drug Corporation by the Defense Logistics Agency (DLA) Troop Support Medical for the supply of a medical product - Epinephrine 0.3 mg Auto-Injector. The delivery order, valued at $3,819.41, is a firm-fixed price contract with an ultimate completion date of August 1, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded multiple federal contracts and indefinite delivery contracts (IDCs) by various defense and civilian...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Epinephrine 0.3 mg auto-injector packs. The ceiling value of this firm-fixed-price contract is $3,941.74, with an ultimate completion date of August 16, 2024. Amerisourcebergen, which has a significant Indefinite Delivery Contract (IDC) with the DLA valued up to $999,999,999 through December 2025, has been a key...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of epinephrine 0.3 mg auto-injector devices. The contract has a ceiling value of $3,043.52 and a completion date of June 24, 2025. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,632.62, is for the delivery of 4,568,165,574 units of Epinephrine 0.3 mg Auto-Injectors. The contract is a firm fixed-price, non-set-aside delivery order with a performance period extending through May 8, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB25FMURU
    Delivery Order

This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of epinephrine 0.3 mg auto-injectors. The $3,287.15 firm fixed price delivery order is not set aside and has an ultimate completion date of July 7, 2025. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle for the Defense Health Agency, U.S. Coast Guard, and other government agencies through December 2026. This delivery order is part of the company's broader role as a critical vendor supporting federal medical procurement needs, particularly for military and veteran healthcare systems.

Generated 10/2/25, 11:13 AM